Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novel Essential-Tremor Treatment Gets US Green Light

Executive Summary

The ExAblate Neuro uses targeted ultrasound to destroy brain tissue linked to tremors. It is the first device of its type to gain approval from the US regulator.

Advertisement

Related Content

Trial Shows InSightec's Tremor Therapy Could Improve With Better Imaging
InSightec’s Focused Ultrasound Shows Early, Positive Data For Disabling Tremor

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

MT103587

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel